Proposed Data Collection Submitted for Public Comment and Recommendations, 68694-68695 [2022-24918]
Download as PDF
<![CDATA[
68694
Federal Register / Vol. 87, No. 220 / Wednesday, November 16, 2022 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–23–23AP; Docket No. CDC–2022–
0128]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other federal
agencies the opportunity to comment on
a proposed information collection, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on a new proposed
information collection project titled
TRANSCEND: Transgender statusneutral community-to-clinic models to
end the HIV epidemic. This project is
designed to collect standardized
program evaluation data from the clinics
and community-based organizations
who receive federal funds for HIV
prevention and care activities.
DATES: CDC must receive written
comments on or before January 17,
2023.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2022–
0128 by either of the following methods:
• Federal eRulemaking Portal:
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS H21–8, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
www.regulations.gov.
SUMMARY:
khammond on DSKJM1Z7X2PROD with NOTICES
Please note: Submit all comments through
the Federal eRulemaking portal
(www.regulations.gov) or by U.S. mail to the
address listed above.
To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS
FOR FURTHER INFORMATION CONTACT:
VerDate Sep<11>2014
17:27 Nov 15, 2022
Jkt 259001
H21–8, Atlanta, Georgia 30329;
Telephone: 404–639–7118; Email: omb@
cdc.gov.
SUPPLEMENTARY INFORMATION:
Under the Paperwork Reduction Act
of 1995 (PRA) (44 U.S.C. 3501–3520),
federal agencies must obtain approval
from the Office of Management and
Budget (OMB) for each collection of
information they conduct or sponsor. In
addition, the PRA also requires federal
agencies to provide a 60-day notice in
the Federal Register concerning each
proposed collection of information,
including each new proposed
collection, each proposed extension of
existing collection of information, and
each reinstatement of previously
approved information collection before
submitting the collection to the OMB for
approval. To comply with this
requirement, we are publishing this
notice of a proposed data collection as
described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
Proposed Project
TRANSCEND: Transgender statusneutral community-to-clinic models to
end the HIV epidemic—New—National
Center for HIV, Viral Hepatitis, STD,
and TB Prevention (NCHHSTP), Centers
for Disease Control and Prevention
(CDC).
Background and Brief Description
Transgender (TG) persons, especially
transgender women (TGW), have a high
prevalence of HIV and lifetime risk of
acquiring HIV. In the 2019–2020
National HIV Behavioral Surveillance
Trans cycle, 42% of TGW tested
positive for HIV. Racial/ethnic
disparities were also found, with HIV
PO 00000
Frm 00027
Fmt 4703
Sfmt 4703
positivity rates of 62% among Black/
African American TGW and 35% among
Hispanic/Latina TGW compared to 17%
among White TGW. Despite the
disproportionate burden of HIV among
TGW, receipt of HIV prevention and
care services have been suboptimal.
Among TG persons, 92% reported that
they were aware of pre-exposure
prophylaxis (PrEP) but only 32% had
used it. In 2019, viral suppression
among persons with diagnosed HIV was
67% among TGW. Large proportions of
TG persons experience poverty,
homelessness, abuse, and have
substance use or mental health
disorders, which impact access to and
utilization of HIV prevention and care
services. Many TG persons seek genderaffirming care, including hormone
therapy, at transgender healthcare
organizations (TG clinics), and these
encounters provide opportunities for
HIV testing and status-neutral HIV
services.
In the proposed demonstration
project, TG clinics and transgenderserving community-based organizations
(CBOs) will work collaboratively to
develop and evaluate community-toclinic models to provide integrated
status-neutral HIV prevention and care
services, gender-affirming services
including hormone therapy, and
primary healthcare, as well as to ensure
access to mental health, substance use,
and social support services. All services
will be culturally and linguistically
responsive for TG persons to ensure that
they feel welcomed, heard, and cared
for. The recipients will also participate
in a national learning collaborative to
share lessons learned and best practices
for TG clinic and TG CBO partnerships
to provide status-neutral, community-toclinic services for TG persons.
This collection of deidentified data
will allow CDC to assist TG clinics and
CBOs in monitoring and evaluating their
programs and to identify best practices
for providing status-neutral HIV services
and comprehensive healthcare for TG
persons and for community-to-clinic
models of service provision.
Longitudinal person-level data
collection will occur through the
clinic’s electronic health record (EHR)
and a database shared between clinic
and CBOs, and additional program
evaluation data will be collected
through client surveys.
CDC requests OMB approval for an
estimated 329 annual burden hours for
the recipients to collect, enter or upload,
and report client demographic and
behavioral characteristics, client data
from the EHR, and client surveys. There
are no other costs to respondents other
than their time to participate.
E:\FR\FM\16NON1.SGM
16NON1
68695
Federal Register / Vol. 87, No. 220 / Wednesday, November 16, 2022 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Total burden
(in hours)
Form name
TRANSCEND Recipient Data Manager.
TRANSCEND Recipient Data Manager.
Electronic Health Record Data Form
4
2
8
64
Client Info Form ...............................
4
2
2
16
TRANSCEND
TRANSCEND
TRANSCEND
TRANSCEND
ager.
Client
Client
Client
Client
Info Form ...............................
Info Form ...............................
Program Evaluation Survey ...
Program Evaluation Survey ...
1,000
8
1,000
4
1
100
1
2
5/60
5/60
5/60
2
83
67
83
16
...........................................................
........................
........................
........................
329
Clients ........................
CBO Staff ..................
Clients ........................
Recipient Data Man-
Total ...........................................
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2022–24918 Filed 11–15–22; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–23–1233]
Agency Forms Undergoing Paperwork
Reduction Act Review
khammond on DSKJM1Z7X2PROD with NOTICES
Average
burden per
response
(in hours)
Number of
responses per
respondent
Number of
respondents
Type of respondent
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled ‘‘Paul Coverdell
National Acute Stroke Program
(PCNASP) 2021–2024 Evaluation’’ to the
Office of Management and Budget
(OMB) for review and approval. CDC
previously published a ‘‘Proposed Data
Collection Submitted for Public
Comment and Recommendations’’
notice on May 23, 2022 to obtain
comments from the public and affected
agencies. CDC did not receive comments
related to the previous notice. This
notice serves to allow an additional 30
days for public and affected agency
comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
VerDate Sep<11>2014
17:27 Nov 15, 2022
Jkt 259001
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
Proposed Project
Paul Coverdell National Acute Stroke
Program (PCNASP) (DP21–2102)
Evaluation (OMB Control No. 0920–
1233)—Reinstatement with Change—
National Center for Chronic Disease
Prevention and Health Promotion
(NCCDPHP), Centers for Disease Control
and Prevention (CDC).
PO 00000
Frm 00028
Fmt 4703
Sfmt 4703
Background and Brief Description
The Centers for Disease Control and
Prevention (CDC), Division for Heart
Disease and Stroke Prevention (DHDSP),
requests OMB approval for a
Reinstatement of a previously approved
data collection. The CDC is the primary
federal agency for protecting health and
promoting quality of life through the
prevention and control of disease,
injury, and disability. CDC is committed
to programs that reduce the health and
economic consequences of the leading
causes of death and disability, thereby
ensuring a long, productive, healthy life
for all people.
Stroke remains a leading cause of
serious, long-term disability and is the
fifth leading cause of death in the
United States after heart disease, cancer,
chronic lower respiratory diseases, and
accidents. Estimates indicate that
approximately 795,000 people suffer a
first-ever or recurrent stroke each year
with more than 146,000 deaths
annually. Although there have been
significant advances in preventing and
treating stroke, the rising prevalence of
heart disease, diabetes, and obesity has
increased the relative risk for stroke,
especially in African American
populations. Moreover, stroke’s lifetime
direct cost of health care and indirect
cost of lost productivity is staggering
and imposes a substantial societal
economic burden. There is a critical
need to improve access to and quality of
care for those at highest risk for events
and stroke patients among the
continuum of care, particularly among
high burden populations. Coverdellfunded state programs are in the
forefront of developing and
implementing system-change efforts to
improve stroke systems of care using
strategies like linking and using data,
using team based approaches to
coordinate stroke care, and providing
community resources to reach the
E:\FR\FM\16NON1.SGM
16NON1
]]>Agencies
[Federal Register Volume 87, Number 220 (Wednesday, November 16, 2022)]
[Notices]
[Pages 68694-68695]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-24918]
[[Page 68694]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-23-23AP; Docket No. CDC-2022-0128]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
federal agencies the opportunity to comment on a proposed information
collection, as required by the Paperwork Reduction Act of 1995. This
notice invites comment on a new proposed information collection project
titled TRANSCEND: Transgender status-neutral community-to-clinic models
to end the HIV epidemic. This project is designed to collect
standardized program evaluation data from the clinics and community-
based organizations who receive federal funds for HIV prevention and
care activities.
DATES: CDC must receive written comments on or before January 17, 2023.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2022-
0128 by either of the following methods:
Federal eRulemaking Portal: www.regulations.gov. Follow
the instructions for submitting comments.
Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS H21-8, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to www.regulations.gov.
Please note: Submit all comments through the Federal eRulemaking
portal (www.regulations.gov) or by U.S. mail to the address listed
above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS H21-8, Atlanta, Georgia 30329; Telephone: 404-639-7118;
Email: [email protected].
SUPPLEMENTARY INFORMATION:
Under the Paperwork Reduction Act of 1995 (PRA) (44 U.S.C. 3501-
3520), federal agencies must obtain approval from the Office of
Management and Budget (OMB) for each collection of information they
conduct or sponsor. In addition, the PRA also requires federal agencies
to provide a 60-day notice in the Federal Register concerning each
proposed collection of information, including each new proposed
collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected;
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses; and
5. Assess information collection costs.
Proposed Project
TRANSCEND: Transgender status-neutral community-to-clinic models to
end the HIV epidemic--New--National Center for HIV, Viral Hepatitis,
STD, and TB Prevention (NCHHSTP), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
Transgender (TG) persons, especially transgender women (TGW), have
a high prevalence of HIV and lifetime risk of acquiring HIV. In the
2019-2020 National HIV Behavioral Surveillance Trans cycle, 42% of TGW
tested positive for HIV. Racial/ethnic disparities were also found,
with HIV positivity rates of 62% among Black/African American TGW and
35% among Hispanic/Latina TGW compared to 17% among White TGW. Despite
the disproportionate burden of HIV among TGW, receipt of HIV prevention
and care services have been suboptimal. Among TG persons, 92% reported
that they were aware of pre-exposure prophylaxis (PrEP) but only 32%
had used it. In 2019, viral suppression among persons with diagnosed
HIV was 67% among TGW. Large proportions of TG persons experience
poverty, homelessness, abuse, and have substance use or mental health
disorders, which impact access to and utilization of HIV prevention and
care services. Many TG persons seek gender-affirming care, including
hormone therapy, at transgender healthcare organizations (TG clinics),
and these encounters provide opportunities for HIV testing and status-
neutral HIV services.
In the proposed demonstration project, TG clinics and transgender-
serving community-based organizations (CBOs) will work collaboratively
to develop and evaluate community-to-clinic models to provide
integrated status-neutral HIV prevention and care services, gender-
affirming services including hormone therapy, and primary healthcare,
as well as to ensure access to mental health, substance use, and social
support services. All services will be culturally and linguistically
responsive for TG persons to ensure that they feel welcomed, heard, and
cared for. The recipients will also participate in a national learning
collaborative to share lessons learned and best practices for TG clinic
and TG CBO partnerships to provide status-neutral, community-to-clinic
services for TG persons.
This collection of deidentified data will allow CDC to assist TG
clinics and CBOs in monitoring and evaluating their programs and to
identify best practices for providing status-neutral HIV services and
comprehensive healthcare for TG persons and for community-to-clinic
models of service provision. Longitudinal person-level data collection
will occur through the clinic's electronic health record (EHR) and a
database shared between clinic and CBOs, and additional program
evaluation data will be collected through client surveys.
CDC requests OMB approval for an estimated 329 annual burden hours
for the recipients to collect, enter or upload, and report client
demographic and behavioral characteristics, client data from the EHR,
and client surveys. There are no other costs to respondents other than
their time to participate.
[[Page 68695]]
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondent Form name Number of responses per per response Total burden
respondents respondent (in hours) (in hours)
----------------------------------------------------------------------------------------------------------------
TRANSCEND Recipient Data Electronic 4 2 8 64
Manager. Health Record
Data Form.
TRANSCEND Recipient Data Client Info Form 4 2 2 16
Manager.
---------------------------------------------------------------
TRANSCEND Clients............. Client Info Form 1,000 1 5/60 83
TRANSCEND CBO Staff........... Client Info Form 8 100 5/60 67
TRANSCEND Clients............. Client Program 1,000 1 5/60 83
Evaluation
Survey.
TRANSCEND Recipient Data Client Program 4 2 2 16
Manager. Evaluation
Survey.
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 329
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2022-24918 Filed 11-15-22; 8:45 am]
BILLING CODE 4163-18-P
